Rebalancing resources for healthcare and medicines: How much is enough?
This report identifies two key policy objectives that can be generated from healthcare and pharmaceutical spending.
Industries
Healthcare
CRA combines in-depth industry knowledge and cutting-edge analytics to evaluate issues being litigated and debated in the healthcare sector. Our industry knowledge enables us to explain, for example, the nuances of provider reimbursement or the patient incentives created by high deductible health insurance plans, and our economic, statistical, accounting, investigative, and finance skills—as well as our familiarity with key healthcare datasets—equips CRA to provide rigorous, defensible analyses tailored to the specific facts of a litigation or regulatory dispute.
Our experts have broad and deep experience in the healthcare sector including hospitals, physician practices, health insurance and health benefit plans, ACOs, PBMs, wholesalers, pharmacies, pharmaceuticals and biologicals, medical devices, clinical laboratories, dialysis facilities, ambulance transport, nursing homes, and home healthcare.
Engagements
- 01Audit of PTO accrual in a unionized workforceCRA’s Labor & Employment Practice was retained to conduct an audit of paid time off accrualsView engagement
- 02CRA Competition team advises GTCR/Biocoat and SurmodicsBiocoat and Surmodics are two medical device coating companies that provide hydrophilic coatings. Medical device manufacturers use hydrophilic coatings to...View engagement
- 03Audit of regular rate calculations in a unionized workforceCRA’s Labor & Employment consultants were retained on behalf of a client in the healthcare and transportation industries to conduct a comprehensive auditView engagement